Sale!

Blood Coagulation Panel NGS Genetic Test

4,400 د.إ

-27%

The Blood Coagulation Panel NGS Genetic Test offered by DNA Labs UAE is a comprehensive genetic screening designed to identify mutations and genetic variants that may affect blood clotting processes. This test is particularly valuable for individuals with a personal or family history of blood clotting disorders, such as deep vein thrombosis, hemophilia, or thrombophilia, among others. By utilizing Next-Generation Sequencing (NGS) technology, this panel can accurately analyze multiple genes associated with coagulation pathways, providing insights into an individual’s risk factors for developing coagulation disorders.

The cost of the Blood Coagulation Panel NGS Genetic Test is 4400 AED. This investment in health can be pivotal in guiding clinical decisions, including the management and treatment of coagulation disorders. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures high-quality, reliable results, allowing for personalized healthcare strategies based on one’s genetic makeup. Whether for diagnostic, predictive, or preventive purposes, this genetic test serves as a critical tool in understanding and managing blood coagulation-related health issues.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Blood Coagulation Panel NGS Genetic Test

Cost: AED 4400.0

Test Name:

Blood Coagulation Panel NGS Genetic DNA Test

Components:

Price: AED 4400.0

Sample Condition:

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery:

3 to 4 Weeks

Method:

NGS Technology

Test Type:

Hematology

Doctor:

Hematologist

Test Department:

Genetics

Pre Test Information:

Clinical History of Patient who is going for Blood Coagulation Panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ACTN1, ACVRL1, ADAMTS13, ADAMTS2, ANKRD26, AP3B1, BLOC1S3, BLOC1S6, CCM2, CD36, CD40LG, CHST14, COL1A2, COL3A1, COL4A1, CTC1, CYCS, DIAPH1, DTNBP1, EFEMP2, ENG, F10, F11, F13A1, F2, F5, F7, F8, F9, FANCA, FGA, FGB, FGG, FLNA, GATA1, GFI1B, GNE, GP1BA, GP1BB, GP9, HOXA11, HPS1, HPS3, HPS4, HPS5, HPS6, IL2RG, ITGA2B, ITGB3, JAM3, KRIT1, LYST, LYZ, MPL, MYH9, P2RY12, PDCD10, PROC, PROS1, PTPN11, RBM8A, RUNX1, SBDS, SERPINC1, SLC35A1, SLC7A7, SMAD4, STIM1, THBD, VIPAS39, WAS

Test Details:

The Blood Coagulation Panel NGS Genetic DNA Test is a genetic test that analyzes an individual’s DNA to identify genetic variations that may affect blood clotting. This test can help diagnose inherited blood clotting disorders, such as hemophilia, von Willebrand disease, and thrombophilia. It can also provide information about an individual’s risk for developing blood clots, which can lead to conditions such as deep vein thrombosis and pulmonary embolism.

NGS (Next Generation Sequencing) is a technology used in this test to sequence multiple genes at once, allowing for a more comprehensive analysis of an individual’s DNA. The results of the test can help guide treatment and management strategies for individuals with blood clotting disorders or those at risk for developing blood clots.

It is important to note that genetic testing has limitations, and a positive result does not necessarily mean an individual will develop a blood clotting disorder or condition. Genetic counseling may be recommended to help individuals understand the implications of their test results.

 

Test NameBlood coagulation panel NGS Genetic DNA Test
Components 
Price4400.0 AED
Sample ConditionBlood or Extracted DNA or One drop Blood on FTA Card
Report Delivery3 to 4 Weeks
MethodNGS Technology
Test typeHematology
DoctorHematologist
Test Department:Genetics
Pre Test InformationClinical History of Patient who is going for Blood coagulation panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ACTN1, ACVRL1, ADAMTS13, ADAMTS2, ANKRD26, AP3B1, BLOC1S3, BLOC1S6, CCM2, CD36, CD40LG, CHST14, COL1A2, COL3A1, COL4A1, CTC1, CYCS, DIAPH1, DTNBP1, EFEMP2, ENG, F10, F11, F13A1, F2, F5, F7, F8, F9, FANCA, FGA, FGB, FGG, FLNA, GATA1, GFI1B, GNE, GP1BA, GP1BB, GP9, HOXA11, HPS1, HPS3, HPS4, HPS5, HPS6, IL2RG, ITGA2B, ITGB3, JAM3, KRIT1, LYST, LYZ, MPL, MYH9, P2RY12, PDCD10, PROC, PROS1, PTPN11, RBM8A, RUNX1, SBDS, SERPINC1, SLC35A1, SLC7A7, SMAD4, STIM1, THBD, VIPAS39, WAS
Test Details

The Blood coagulation panel NGS Genetic DNA Test is a genetic test that analyzes an individual’s DNA to identify genetic variations that may affect blood clotting. This test can help diagnose inherited blood clotting disorders, such as hemophilia, von Willebrand disease, and thrombophilia. It can also provide information about an individual’s risk for developing blood clots, which can lead to conditions such as deep vein thrombosis and pulmonary embolism.

NGS (Next Generation Sequencing) is a technology used in this test to sequence multiple genes at once, allowing for a more comprehensive analysis of an individual’s DNA. The results of the test can help guide treatment and management strategies for individuals with blood clotting disorders or those at risk for developing blood clots.

It is important to note that genetic testing has limitations, and a positive result does not necessarily mean an individual will develop a blood clotting disorder or condition. Genetic counseling may be recommended to help individuals understand the implications of their test results.